By understanding your genetic predispositions, you and your provider can time dose escalations to maximize efficacy while minimizing discomfort
Cette stratgie nest pas recommande
A few of which are: diarrhea, pain, unintentional weight loss, ulcers, malaise, anemia, and anal fissures
Failure to refrigerate between doses causes rapid degradation and loss of effectiveness
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide were studied in STEP (NEJM 2021), SURMOUNT (NEJM 2022), and SURMOUNT-OSA (NEJM 2024)
These effects result from delayed gastric emptying and are usually mild to moderate in severity